Acrivon Therapeutics, Inc. (ACRV) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US0048901096
Acrivon Therapeutics, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Operating income | -84.11 m USD |
| EBIT | -77.91 m USD |
| Net income | -77.91 m USD |
| Diluted EPS – continuing operations | -2.02 USD |
Full history since 2020, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Acrivon Therapeutics, Inc.
Acrivon Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops oncology medicines for patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its generative phosphoproteomics platform. The company operates Acrivon Predictive Precision Proteomics (AP3), a precision medicine platform that enables the creation of drug specific proprietary OncoSignature companion diagnostics that are used to identify the patients to benefit from its drug candidates. Its lead clinical candidate is ACR-368, a selective small molecule inhibitor targeting CHK1 and CHK2 for the treatment of patients with endometrial and platinum-resistant ovarian cancer, and SCCs, such as SCCHN and anal cancer. The company is also developing ACR-2316, a dual WEE1 and PKMYT1 inhibitor small molecule candidate; and a preclinical stage AP3-and co-crystallography-based preclinical cell cycle program. The company was incorporated in 2018 and is based in Watertown, Massachusetts.
More stocks
- SUI Group Holdings Ltd. (SUIG)
- Thorney Opportunities Ltd (TOP.AX)
- BIG SKY INDUSTRIAL INC. (BSIN)
- Choong Ang Vaccine Laboratory Co. Ltd (072020.KQ)
- Hankook Cosmet (123690.KS)
- Afastor Corporation (6707.TWO)
- NETSOL TECHNOLOGIES INC (NTWK)
- Concorde International Group Ltd Class A Ordinary Shares (CIGL)
- WRAP TECHNOLOGIES, INC. (WRAP)
- Richmond International Travel & Tours Co Ltd (2743.TWO)
- Sangsangin Investment & Securities Co Ltd (001290.KS)
- Korea Pharmacy Co. Ltd. (032300.KQ)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.